Benefits of SGLT2 inhibitors combining with renin–angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis-Reference-Cited by-同舟云学术

Benefits of SGLT2 inhibitors combining with renin–angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis

Published:2021-12 Issue: Volume: Page:
ISSN:0025-7753
Container-title:Medicina Clínica
language:en
Short-container-title:Medicina Clínica

Author:

Liu Ting,Li Rui,Wang Xiaoxia,Gao Xingxing,Zhang Xiaodong

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Chronic kidney disease: global dimension and perspectives;Jha;Lancet (Lond, Engl),2013

2. Chronic kidney disease;Webster;Lancet (Lond, Engl),2017

3. Cause of death in patients with reduced kidney function;Thompson;J Am Soc Nephrol,2015

4. Use of renin–angiotensin system blockade in advanced CKD: an NKF-KDOQI controversies report;Weir;Am J Kidney Dis,2018

5. End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study;Lee;Intern Med J,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits;Cellular Signalling;2024-10

2. Impact of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Chronic Kidney Disease: A Middle East and Africa Perspective;International Journal of Nephrology and Renovascular Disease;2024-01

3. Risk Factors for Atherosclerotic Cardiovascular Disease;Preventive Cardiovascular Nursing;2024

4. Podocyte-Related Mechanisms Underlying Survival Benefit of Long-Term Angiotensin Receptor Blocker;International Journal of Molecular Sciences;2022-05-27